Navigation Links
Biomarkers Market worth $40.8 Billion by 2018
Date:9/23/2013

DALLAS, September 23, 2013 /PRNewswire/ --

The "Biomarkers Market - ([Discovery Technologies - Proteomics, Genomics, Imaging, Bioinformatics], Validation Services, Applications [drug development, personalized medicine], Diseases [Oncology, Cardiology, Neurology]) - Global Trends & Forecasts (2013 - 2018)", analyzes & studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, & Rest of the World (ROW).

Browse 131 market data tables and 23 figures spread through 327 pages and in-depth TOC on "Biomarkers Market"
http://www.marketsandmarkets.com/Market-Reports/biomarkers-advanced-technologies-and-global-market-43.html
Early buyers will receive 10% customization on this report.

This report studies the global Biomarkers Market over the forecast period of 2013 to 2018. A number of factors such as the rising demand for personalized medicine and companion diagnostics have increased the utility of Biomarkers in the healthcare sector. The global Biomarkers Market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.

Omics technology including, proteomics, genomics, transcriptomics, and metabolomics, is the largest segment of the global Biomarkers discovery technology market. Advancement in discovery technologies such as genome sequencing is the prime factor contributing to the growth of this market.

The discovery and development of Biomarkers is costly and is a highly time consuming procedure. Application of Biomarkers in drug discovery & development reduces the overall cost of the entire drug development process; hence, demand for novel Biomarkers is expected to increase in the next five years. Discovery and development of potent Biomarkers require thorough technological knowledge and expertise. Thus, in order to get access to highly sophisticated technologies & to divide the cost burden, partnerships and collaborations is the major strategy followed by market players. Companies such as Roche Diagnostics Limited (Switzerland), Johnson & Johnson (U.S.), Siemens Healthcare (Germany), Abbott Laboratories, Inc. (U.S.), and Bio-Rad Laboratories, Inc. (U.S.) are actively adopting the strategy of partnerships and collaborations, to ensure their growth in the Biomarkers Market.

From an insight perspective, this research report has focused on various levels of analysis which includes company profiles (comprises and discusses the views on competitive landscape), emerging and high growth segments of the Biomarkers Market, emerging discovery technologies, high growth regions and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities. The above mentioned market research data, current market size, and forecast of future trends will help the existing players and new entrants to make necessary decisions regarding product offerings, geographic focus, strategic approach, R&D investment for innovation in products and technologies, and levels of output, in order to remain successful in the Biomarkers Market.

Browse related reports

In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017

http://www.marketsandmarkets.com/Market-Reports/ivd-in-vitro-diagnostics-market-703.html

Proteomics Market (Protein Microarray, Mass Spectrometry, NMR Spectroscopy, Chromatography, Electrophoresis, Surface Plasmon Resonance, X-ray Crystallography) - Instruments, Reagents & Services - Trends & Global Forecasts to 2017

http://www.marketsandmarkets.com/Market-Reports/proteomics-market-731.html

About MarketsandMarkets

MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, agriculture industry, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://www.marketsandmarketsblog.com/market-reports/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets


'/>"/>
SOURCE MarketsandMarkets
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Biomarkers: Technological and Commercial Outlook 2013-2023
2. Biomarkers predict time to ovarian cancer recurrence
3. Epigenetic and MicroRNA Biomarkers 2013 Market Report
4. Biomarkers - Technologies, Markets and Companies - Updated 2012 Report
5. Molecular Biomarkers for Cancer Detection and Management
6. Quantitative Analysis of Biomarkers, New Life Science Webinar Hosted by Xtalks
7. Pacific Biomarkers and Clinigene International To Announce Laboratory Solutions for Developers of Biosimilars at 2013 AAPS/ National Biotechnology Conference
8. MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
9. Discovery of Circulating Protein Biomarkers by Analysis of the Tissue Secretome, New Life Science Webinar Hosted by Xtalks
10. Central Nervous System (CNS) Biomarkers Market: 2017 Forecast in New Research Report at ReportsnReports.com
11. Advanced Cell Diagnostics Initiates Agreement to Study Biomarkers for Cancer Immunotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... , June 27, 2016  Sequenom, Inc. (NASDAQ: ... enabling healthier lives through the development of innovative products ... the United States denied its ... the claims of Sequenom,s U.S. Patent No. 6,258,540 (",540 ... criteria established by the Supreme Court,s Mayo Collaborative Services ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica delle ... people with peritoneal or pleural mesothelioma. Their findings are the subject of a new ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of mesothelioma ...
(Date:6/23/2016)... June 23, 2016 A person commits a crime, ... scene to track the criminal down. An outbreak ... and Drug Administration (FDA) uses DNA evidence to track down ... Sound far-fetched? It,s not. The FDA has increasingly used ... investigations of foodborne illnesses. Put as simply as possible, whole ...
Breaking Biology Technology:
(Date:6/3/2016)... , June 3, 2016 ... von Nepal hat ... Lieferung hochsicherer geprägter Kennzeichen, einschließlich Personalisierung, Registrierung ... in der Produktion und Implementierung von Identitätsmanagementlösungen. ... Ausschreibung im Januar teilgenommen, aber Decatur wurde ...
(Date:5/24/2016)... -- Ampronix facilitates superior patient care by providing unparalleled technology to leaders of the ... latest premium product recently added to the range of products distributed by Ampronix. ... ... ... Display- Ampronix News ...
(Date:5/3/2016)... 2016  Neurotechnology, a provider of high-precision biometric ... Biometric Identification System (ABIS) , a complete system ... ABIS can process multiple complex biometric transactions with ... fingerprint, face or iris biometrics. It leverages the ... MegaMatcher Accelerator , which have been used ...
Breaking Biology News(10 mins):